A study to find out if a new medicine (either astegolimab or efmarodocokin alfa) was safe and effective in patients with severe COVID-19 pneumonia

A Study to Evaluate the Safety and Efficacy of MSTT1041A (Astegolimab) or UTTR1147A in Patients With Severe COVID-19 Pneumonia

Infectious Diseases
COVID-19 Pneumonia

Results
Download
Print

Study results

LPS_GA42469_final results_October2021_English (PDF, 0.1 MB)

LPS_GA42469_final results_October2021_Portuguese_Brazil (PDF, 0.1 MB)

LPS_GA42469_final results_October2021_Spanish_Mexico (PDF, 0.1 MB)

LPS_GA42469_final results_October2021_Spanish_Spain (PDF, 0.1 MB)

LPS_GA42469_final results_October2021_Spanish_US (PDF, 0.1 MB)

What is Clinical Research?

In clinical research, volunteers, researchers, and medical professionals work together toward a shared goal: better treatment outcomes for patients. Clinical trials are vital to their process. They are carefully designed and follow approved protocols.

A study to find out if a new medicine (either astegolimab or efmarodocokin alfa) was safe and effective in patients with severe COVID-19 pneumonia

Study results

LPS_GA42469_final results_October2021_English (PDF, 0.1 MB)

LPS_GA42469_final results_October2021_Portuguese_Brazil (PDF, 0.1 MB)

LPS_GA42469_final results_October2021_Spanish_Mexico (PDF, 0.1 MB)

LPS_GA42469_final results_October2021_Spanish_Spain (PDF, 0.1 MB)

LPS_GA42469_final results_October2021_Spanish_US (PDF, 0.1 MB)

What is Clinical Research?

For the latest version of this information please go to www.forpatients.roche.com

Directly contact Roche for questions

Contact the hospital directly

Thank you

Something went wrong

Request a call back

Find participating medical centers and current study status in each of them

A study to find out if a new medicine (either astegolimab or efmarodocokin alfa) was safe and effective in patients with severe COVID-19 pneumonia

For the latest version of this information please go to www.forpatients.roche.com